Quanticate Expands their Global Operations for Biostatistics and Programming in Clinical Trials
Bangalore and North Carolina facilities look to expand staff after the award of two large FSPs
Quanticate, a leading global data-focused
Quanticate is looking to significantly grow its resource capabilities and will be
"The expansion of our current customers coupled with the addition of new partnerships and two large-scale FSPs, has resulted in the need to expand our resource base across all our locations,” explained Daniel Chapple, Chief Commercial Officer. “This expansion will also enable us to extend our presence to other cities in India and we are currently in the process of identifying facilities,” continued Chapple.
The addition of two new partnerships means that Quanticate is now supporting biostatistics and programming for six of the Top 8 pharmaceutical companies and has gained extensive experience in successfully supporting companies in strategic partnerships within the data field. “Many companies are seeing the benefits from companies that can offer global expertise in their niche fields rather than using full service CROs whose primary focus is monitoring and project management,” explains David Underwood, CEO of Quanticate. Underwood continues, “This approach can also drastically reduce operational oversight on the client side where successful partnerships are built on quality, performance, trust and understanding. It also means clients gain from the big benefit of having subject experts supporting their programs of work.”
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025